PURPOSE:
The system is designed to diagnose kidney function and control the quality of hemodialysis.
ADVANTAGES:
There are no commercial analogues of the system. The proposed system differs from the known methods for determining creatinine and urea in that it does not require preliminary sample preparation, has a short analysis duration (express analysis), low labor intensity and cost of analysis, high sensitivity and selectivity of determination, the possibility of simultaneous determination of both metabolites in real-time. at the patient’s bed.
RECOMMENDED FIELD OF APPLICATION:
Medicine.
RESULTS OF THE RESEARCH:
Ready for implementation.
STAGE OF THE DEVELOPMENT READINESS:
Ready for implementation.
TRANSFER OPPORTUNITY:
-
- Joint bringing to the industrial level.
- Sales of finished products.
NOVELTY:
1 patent of Ukraine.
IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,
WRITE TO US